Bolt Biotherapeutics, Inc. Common Stock BOLT
$3.29
+2.49%
at last close
Analyst Consensus
- Consensus Rating
- Buy (3 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $34.67
- Implied Upside
- +953.7%
- Price Target Range
- $7.00 – $75.00
- Analysts (12 mo)
- 3
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-05-29 | Rodman & RenshawMichael G. King Jr. |
Initiates coverage on | Buy | $22 |
| 2026-05-28 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $7 |
| 2026-03-13 | HC Wainwright & Co.Robert Burns |
Reiterates | Buy | $7 |
| 2025-10-20 | HC Wainwright & Co.Robert Burns |
Assumes | Buy | $7 |
| 2025-08-15 | Lake StreetChad Messer |
Maintains | Buy | $4 → $75 |
| 2025-05-20 | Lake StreetChad Messer |
Initiates coverage on | Buy | $4 |
| 2025-05-13 | StifelStephen Willey |
Maintains | Hold | $1 → $1 |
| 2025-03-25 | HC Wainwright & Co.Edward White |
Reiterates | Neutral | — |
| 2025-03-25 | StifelStephen Willey |
Maintains | Hold | $2 → $1 |
| 2024-11-13 | HC Wainwright & Co.Edward White |
Reiterates | Neutral | — |
| 2024-08-15 | HC Wainwright & Co.Edward White |
Reiterates | Neutral | — |
| 2024-05-15 | Leerink PartnersDaina Graybosch |
Downgrades | Outperform → Market perform | $3 → $1 |
| 2024-05-15 | Jones TradingSoumit Roy |
Downgrades | Buy → Hold | — |
| 2024-05-15 | HC Wainwright & Co.Edward White |
Downgrades | Buy → Neutral | — |
| 2024-05-15 | GuggenheimMichael Schmidt |
Downgrades | Buy → Neutral | — |
| 2024-05-15 | StifelStephen Willey |
Downgrades | Buy → Hold | $6 → $2 |
| 2024-03-22 | HC Wainwright & Co.Edward White |
Maintains | Buy | $8 |
| 2023-08-08 | HC Wainwright & Co.Edward White |
Reiterates | Buy | $8 |
| 2023-08-03 | HC Wainwright & Co.Edward White |
Reiterates | Buy | $8 |
| 2023-06-05 | HC Wainwright & Co.Edward White |
Reiterates | Buy | $8 |
| 2023-05-26 | HC Wainwright & Co.Edward White |
Reiterates | Buy | $8 |
| 2023-05-12 | SVB LeerinkDaina Graybosch |
Upgrades | Market perform → Outperform | $4 |
| 2023-05-12 | HC Wainwright & Co.Edward White |
Reiterates | Buy | $8 |
| 2023-03-30 | HC Wainwright & Co.Edward White |
Reiterates | Buy | $8 |
| 2023-01-24 | Morgan StanleyMatthew Harrison |
Maintains | Equal-weight | $5 → $3 |
| 2022-10-04 | HC Wainwright & Co.Edward White |
Initiates coverage on | Buy | $8 |
| 2022-08-11 | SVB LeerinkDaina Graybosch |
Downgrades | Outperform → Market perform | $8 → $4 |
| 2022-05-17 | Morgan StanleyMatthew Harrison |
Maintains | Equal-weight | $7 → $5 |
| 2022-01-06 | Morgan StanleyMatthew Harrison |
Downgrades | Overweight → Equal-weight | $45 → $11 |
| 2021-11-10 | SVB LeerinkDaina Graybosch |
Maintains | Outperform | $35 → $33 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $3.29
- Market Cap
- $6.63 million
- 52-Week Range
- $3.13 – $7.20
- Average Volume
- 21K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.